Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 31 min ago
PreprintCC BY-NC-NDbioRxiv

Variable penetrance of schizophrenia in 22q11.2 deletion syndrome is associated with impaired, but reversible, neuronal mitophagy.

  1. 1Children's Hospital of Philadelphia

Abstract

The 22q11.2 deletion syndrome (22qDS) is a major genetic risk factor for schizophrenia (Sz). We found that iPSC-derived neurons (iNeurons) from 22qDS +Sz individuals exhibit weaker mitochondrial energetics, whereas iNeurons from individuals with the same deletion but no psychosis (22qDS -Sz) upregulate expression of mitochondrial biogenesis-related genes. Here, we investigated why the +Sz group fails to undergo this compensation, finding that 22qDS +Sz iNeurons have older and more depolarized mitochondria than 22qDS -Sz or controls. Transcriptomic and proteomic analyses revealed downregulation of mitophagy-related pathways, and live imaging revealed elevated lysosomal pH. Restoring lysosomal acidity with acidifying nanoparticles improved mitophagy and, remarkably, increased the expression of mitochondrial biogenesis-related transcription factors in the +Sz neurons. We conclude that lysosomal dysfunction and impaired mitophagy differentiate 22qDS individuals who develop schizophrenia from those who do not. Mitophagy could be a novel therapeutic or preventative opportunity for Sz in the context of genetic neurodevelopmental disorders.

Related

  1. Urolithin A Attenuates Noise-induced Hearing Loss and Is Associated With Increased Cochlear Mitophagy Markers
    SUNG IL CHO, EU-RI JO, JEONGHYUN OH
    In VivoPeer-reviewedCC BY-NC-ND 4.0Full textNeurosciencePMC
  2. CCR5, CD163, CSF1R, and FCGR3A as Candidate Biomarkers Associated With Mitophagy in Atherosclerosis.
    Jiadong Fu, Yongda Dong
    Human mutationPeer-reviewedCC BYFull textImmunologyEurope PMC
  3. ABO Blood Group and von Willebrand Factor Levels Partially Explained the Incomplete Penetrance of Congenital Thrombophilia
    William Cohen, Christel Castelli, Marie-Christine Alessi +8
    Arteriosclerosis, Thrombosis, and Vascular BiologyPeer-reviewedLicence not statedFull text28 citedNeuroscienceHAL
  4. Case Report: Late postpartum eclampsia-associated reversible posterior encephalopathy syndrome with anti-DPPX encephalitis
    Xuanlin Xing, Yuyan He, Liumei Ma +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  5. 2-bromopalmitate modulates macrophage polarization and mitophagy through STAT1-associated signaling in immune thrombocytopenia
    Xiaoyuan Fan, Mingwei Li, Danlu Li +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
BibTeX
@misc{stronati2026variable,
  title = {{Variable penetrance of schizophrenia in 22q11.2 deletion syndrome is associated with impaired, but reversible, neuronal mitophagy.}},
  author = {E. Stronati and A. J. Rossano and J. Li and A. R. Stoesser and D. C. Wallace and C. Giulivi and S. A. Anderson},
  howpublished = {bioRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.13.766189},
  url = {https://www.biorxiv.org/content/10.64898/2026.11.13.766189v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Variable penetrance of schizophrenia in 22q11.2 deletion syndrome is associated with impaired, but reversible, neuronal mitophagy.
AU  - E. Stronati
AU  - A. J. Rossano
AU  - J. Li
AU  - A. R. Stoesser
AU  - D. C. Wallace
AU  - C. Giulivi
AU  - S. A. Anderson
PY  - 2026
DA  - 2026/11/13
PB  - bioRxiv
DO  - 10.64898/2026.11.13.766189
UR  - https://www.biorxiv.org/content/10.64898/2026.11.13.766189v1
AB  - The 22q11.2 deletion syndrome (22qDS) is a major genetic risk factor for schizophrenia (Sz). We found that iPSC-derived neurons (iNeurons) from 22qDS +Sz individuals exhibit weaker mitochondrial energetics, whereas iNeurons from individuals with the same deletion but no psychosis (22qDS -Sz) upregulate expression of mitochondrial biogenesis-related genes. Here, we investigated why the +Sz group fails to undergo this compensation, finding that 22qDS +Sz iNeurons have older and more depolarized mitochondria than 22qDS -Sz or controls. Transcriptomic and proteomic analyses revealed downregulation of mitophagy-related pathways, and live imaging revealed elevated lysosomal pH. Restoring lysosomal acidity with acidifying nanoparticles improved mitophagy and, remarkably, increased the expression of mitochondrial biogenesis-related transcription factors in the +Sz neurons. We conclude that lysosomal dysfunction and impaired mitophagy differentiate 22qDS individuals who develop schizophrenia from those who do not. Mitophagy could be a novel therapeutic or preventative opportunity for Sz in the context of genetic neurodevelopmental disorders.
ER  -